NCT02620332View on ClinicalTrials.gov

Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 20, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

April 6, 2018

Conditions
Type 1 Diabetes
Interventions
DRUG

MultiPepT1De injection

A mix of peptides

OTHER

Placebo

Water for injection

Trial Locations (1)

SE1 9RT

Guy's Hospital, London

All Listed Sponsors
collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

lead

King's College London

OTHER

NCT02620332 - Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De) | Biotech Hunter | Biotech Hunter